Jean-Jacques Bertrand
Director/Board Member chez NEOVACS
Profil
Jean-Jacques Bertrand is a businessperson who has been at the head of 13 different companies and currently occupies the position of Chairman at Canadian Network for Vaccines & Immunotherapeutics, Chairman of Viroxis SA and Venture Partner at Truffle Capital SAS.
Mr. Bertrand is also on the board of Pierre Fabre Participations SAS, Neovacs SA (former Chairman) and Brive Rugby SA (former Chairman).
In the past he was Independent Director at Guerbet SA, Chairman-Supervisory Board for Cytheris SA, Chairman at Fédération Françaises des Industries de Santé, CEO-Pharmaceutical Operations at Rhône-Poulenc Santé, Chairman-Supervisory Board of Pierre Fabre SA, Chairman & Chief Executive Officer of Aventis Pasteur Sa, Chairman & Chief Executive Officer at Sanofi Pasteur SA, Chief Executive Officer for Rhone Poulenc Rorer, Deputy Chief Executive Officer of Aventis Pharma SARL and Chairman at Leem.
Jean-Jacques Bertrand received an undergraduate degree from École des Hautes Études Commerciales de Paris.
Postes actifs de Jean-Jacques Bertrand
Sociétés | Poste | Début |
---|---|---|
NEOVACS | Director/Board Member | - |
Brive Rugby SA | Director/Board Member | - |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Director/Board Member | 25/08/2018 |
Viroxis SA | Chairman | - |
Canadian Network for Vaccines & Immunotherapeutics | Chairman | 28/06/2010 |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Private Equity Analyst | 17/12/2009 |
Anciens postes connus de Jean-Jacques Bertrand
Sociétés | Poste | Fin |
---|---|---|
ABIVAX | Director/Board Member | 11/07/2023 |
B3G SA
B3G SA Specialty TelecommunicationsCommunications B3G SA provides broadband telephone operating services. The firm offers b-initial, b-direct, b-centrex, and b-specific services. It serves Internet service providers, cable companies, regional operators, and telecommunication and multimedia professionals. It has operations in France, Italy, Great Britain, Belgium, Denmark, Bulgaria, Romania, and Turkey. The company was founded in 2001 and is headquartered in La Défense, France. | Director/Board Member | 30/10/2013 |
Muzicall Ltd.
Muzicall Ltd. Wireless TelecommunicationsCommunications Muzicall Ltd. provides ringback tone services. It offers its services for mobile operators, corporates, charities, advertising and media companies. The firm offers ringback tone services for fun, business and advertisements. The company was founded in 2004 by Mark Collins and Richard Nigel Curzon Jackson and is headquartered in London, the United Kingdom. | Director/Board Member | 03/07/2013 |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jean-Jacques Bertrand
École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
GUERBET | Health Technology |
NEOVACS | Health Technology |
ABIVAX | Health Technology |
Entreprise privées | 17 |
---|---|
Muzicall Ltd.
Muzicall Ltd. Wireless TelecommunicationsCommunications Muzicall Ltd. provides ringback tone services. It offers its services for mobile operators, corporates, charities, advertising and media companies. The firm offers ringback tone services for fun, business and advertisements. The company was founded in 2004 by Mark Collins and Richard Nigel Curzon Jackson and is headquartered in London, the United Kingdom. | Communications |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Aventis Pasteur Sa | Health Technology |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Health Technology |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the private company is based in Antony, France. | Health Technology |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | Health Technology |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Finance |
B3G SA
B3G SA Specialty TelecommunicationsCommunications B3G SA provides broadband telephone operating services. The firm offers b-initial, b-direct, b-centrex, and b-specific services. It serves Internet service providers, cable companies, regional operators, and telecommunication and multimedia professionals. It has operations in France, Italy, Great Britain, Belgium, Denmark, Bulgaria, Romania, and Turkey. The company was founded in 2001 and is headquartered in La Défense, France. | Communications |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Leem | |
La Fondation pour la Recherche Médicale | |
Canadian Network for Vaccines & Immunotherapeutics | |
Fédération Françaises des Industries de Santé | |
Viroxis SA | |
Brive Rugby SA | |
Rhône-Poulenc Santé |